FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2305116387> ?p ?o ?g. }

• W2305116387 abstract "Background Little is known about how patient factors may effect the impact of biologics on various quality of life measures used in psoriatic arthritis (PsA). Objectives The objective of this study was to perform a systematic review and meta-regression analysis to explore the clinical factors that modify the effects of biologics on quality of life in PsA patients. Methods A systematic literature review was performed in Medline, EMBASE, and Cochrane Central and clinicaltrials.gov. Randomized controlled trials (RCTs) assessing biologics in adults with PsA were eligible. Outcomes of interest included the Health Assessment Questionnaire-Disability Index (HAQ-DI) and the SF-36 Physical Component Summary (PCS) and Mental Component Summary (MCS). Clinical factors evaluated for effect on biologic treatment response were age, gender, ethnicity, PsA duration, psoriasis duration, swollen and tender joint counts, steroid baseline use, methotrexate baseline use, prior anti-TNF use, Disease Activity Score (DAS) and study year. Clinical factors were considered potential effect modifiers (PEM) of quality of life in PsA if they graphically demonstrated associations via forest and l9Abbe plots. PEM were further investigated through meta-regression analyses where covariate effects were assumed to be similar for all treatments. Results Ten placebo-controlled RCTs were identified as eligible for analysis (10 reporting on SF-36 PCS, 9 reporting on SF-36 MCS, and 9 reporting on HAQ-DI). Treatments assessed in these trials included adalimumab, etanercept, infliximab, ustekinumab, abatacept, certolizumab pegol, golimumab and secukinumab. Age was found to be a PEM for HAQ-DI at 12 weeks. When this covariate was examined in meta-regression, trials with higher mean age at baseline tended to have higher HAQ-DI scores. Age and psoriasis duration were PEM for HAQ-DI at 24 weeks. In meta-regression, trials with higher mean age at baseline and shorter PsA duration tended to have higher HAQ-DI scores. Age was identified as a PEM for SF-36 PCS at 12 weeks, but this was not significant in the meta-regression. Psoriasis duration, PsA duration, baseline DAS, and study year were PEM for SF-36 PCS at 24 weeks. Meta-regression analysis of these covariates supported them as effect modifiers, showing trials with shorter psoriasis duration, shorter PsA duration, and more recent study year tended to have lower SF-36 PCS scores. DAS was not found to be related to SF-36 PCS scores. Age and white race were identified as PEM of SF-36 MCS at 12 weeks, but these were not significant in meta-regression. Age was identified as a PEM for SF-36 MCS at 24 weeks. When this was considered in meta-regression, trials with higher mean age at baseline tended to have lower SF-36 MCS scores. Conclusions These analyses identified key clinical factors such as age and disease duration, which modify the effects of biologics on quality of life. Accounting for these clinical factors in future real world clinical or pharmacoepidemiologic studies may be important to ensure the best evidence is used for biologic coverage and treatment decision-making. Disclosure of Interest J. Palmer Employee of: Novartis Pharmaceuticals Corporation, S. Kanter Consultant for: Novartis Pharmaceuticals Corporation, E. Druyts Consultant for: Novartis Pharmaceuticals Corporation, Y. Tsang Employee of: Novartis Pharmaceuticals Corporation, V. Herrera Employee of: Novartis Pharmaceuticals Corporation" @default.
• W2305116387 created "2016-06-24" @default.
• W2305116387 creator A5016598918 @default.
• W2305116387 creator A5035790945 @default.
• W2305116387 creator A5054425112 @default.
• W2305116387 creator A5063294295 @default.
• W2305116387 creator A5065966188 @default.
• W2305116387 date "2015-06-01" @default.
• W2305116387 modified "2023-09-23" @default.
• W2305116387 title "AB0810 Clinical Factors That Modify the Effects of Biologics on Quality of Life: A Case Study in Psoriatic Arthritis" @default.
• W2305116387 doi "https://doi.org/10.1136/annrheumdis-2015-eular.4051" @default.
• W2305116387 hasPublicationYear "2015" @default.
• W2305116387 type Work @default.
• W2305116387 sameAs 2305116387 @default.
• W2305116387 citedByCount "0" @default.
• W2305116387 crossrefType "journal-article" @default.
• W2305116387 hasAuthorship W2305116387A5016598918 @default.
• W2305116387 hasAuthorship W2305116387A5035790945 @default.
• W2305116387 hasAuthorship W2305116387A5054425112 @default.
• W2305116387 hasAuthorship W2305116387A5063294295 @default.
• W2305116387 hasAuthorship W2305116387A5065966188 @default.
• W2305116387 hasConcept C111278954 @default.
• W2305116387 hasConcept C126322002 @default.
• W2305116387 hasConcept C159110408 @default.
• W2305116387 hasConcept C168563851 @default.
• W2305116387 hasConcept C1862650 @default.
• W2305116387 hasConcept C2776215756 @default.
• W2305116387 hasConcept C2776260265 @default.
• W2305116387 hasConcept C2777138892 @default.
• W2305116387 hasConcept C2777226972 @default.
• W2305116387 hasConcept C2777575956 @default.
• W2305116387 hasConcept C2778975655 @default.
• W2305116387 hasConcept C2779134260 @default.
• W2305116387 hasConcept C2779338263 @default.
• W2305116387 hasConcept C2779605438 @default.
• W2305116387 hasConcept C2779786854 @default.
• W2305116387 hasConcept C2779951463 @default.
• W2305116387 hasConcept C2780132546 @default.
• W2305116387 hasConcept C2780653079 @default.
• W2305116387 hasConcept C2781290027 @default.
• W2305116387 hasConcept C535046627 @default.
• W2305116387 hasConcept C71924100 @default.
• W2305116387 hasConceptScore W2305116387C111278954 @default.
• W2305116387 hasConceptScore W2305116387C126322002 @default.
• W2305116387 hasConceptScore W2305116387C159110408 @default.
• W2305116387 hasConceptScore W2305116387C168563851 @default.
• W2305116387 hasConceptScore W2305116387C1862650 @default.
• W2305116387 hasConceptScore W2305116387C2776215756 @default.
• W2305116387 hasConceptScore W2305116387C2776260265 @default.
• W2305116387 hasConceptScore W2305116387C2777138892 @default.
• W2305116387 hasConceptScore W2305116387C2777226972 @default.
• W2305116387 hasConceptScore W2305116387C2777575956 @default.
• W2305116387 hasConceptScore W2305116387C2778975655 @default.
• W2305116387 hasConceptScore W2305116387C2779134260 @default.
• W2305116387 hasConceptScore W2305116387C2779338263 @default.
• W2305116387 hasConceptScore W2305116387C2779605438 @default.
• W2305116387 hasConceptScore W2305116387C2779786854 @default.
• W2305116387 hasConceptScore W2305116387C2779951463 @default.
• W2305116387 hasConceptScore W2305116387C2780132546 @default.
• W2305116387 hasConceptScore W2305116387C2780653079 @default.
• W2305116387 hasConceptScore W2305116387C2781290027 @default.
• W2305116387 hasConceptScore W2305116387C535046627 @default.
• W2305116387 hasConceptScore W2305116387C71924100 @default.
• W2305116387 hasLocation W23051163871 @default.
• W2305116387 hasOpenAccess W2305116387 @default.
• W2305116387 hasPrimaryLocation W23051163871 @default.
• W2305116387 hasRelatedWork W1993960016 @default.
• W2305116387 hasRelatedWork W2013161261 @default.
• W2305116387 hasRelatedWork W2022466169 @default.
• W2305116387 hasRelatedWork W2127937781 @default.
• W2305116387 hasRelatedWork W2328017783 @default.
• W2305116387 hasRelatedWork W2332537654 @default.
• W2305116387 hasRelatedWork W2539870148 @default.
• W2305116387 hasRelatedWork W2555537140 @default.
• W2305116387 hasRelatedWork W2754919623 @default.
• W2305116387 hasRelatedWork W2790247036 @default.
• W2305116387 hasRelatedWork W2806224497 @default.
• W2305116387 hasRelatedWork W2903053212 @default.
• W2305116387 hasRelatedWork W2909956025 @default.
• W2305116387 hasRelatedWork W2989706656 @default.
• W2305116387 hasRelatedWork W2995742512 @default.
• W2305116387 hasRelatedWork W2995910690 @default.
• W2305116387 hasRelatedWork W3001441289 @default.
• W2305116387 hasRelatedWork W3084231652 @default.
• W2305116387 hasRelatedWork W3121728640 @default.
• W2305116387 hasRelatedWork W3202407885 @default.
• W2305116387 isParatext "false" @default.
• W2305116387 isRetracted "false" @default.
• W2305116387 magId "2305116387" @default.
• W2305116387 workType "article" @default.